Quidel regulatory update

QDEL filed a 510k for SafePlan, a 5-minute urine test that detects the post-ovulatory infertile period by measuring the hormone metabolite pregnanediol glucuronide. QDEL estimated a market of about four million women, who would pay about $8 to $15 per month. ...